Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HERITAGE PHARMA

  • FDA Approval
  • Nov. 26, 2024, 09:46 UTC
  • 32
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

RICONPHARMA LLC

  • FDA Approval
  • Nov. 26, 2024, 05:31 UTC
  • 46
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

MAIA PHARMS INC

  • FDA Approval
  • Nov. 26, 2024, 05:31 UTC
  • 30
  • 0 comments

FDA approve DAPTOMYCIN

Comment Full text

SHORLA

  • FDA Approval
  • Nov. 25, 2024, 15:19 UTC
  • 45
  • 0 comments

FDA approve IMATINIB

Comment Full text

BRIDGEBIO PHARMA INC

  • FDA Approval
  • Nov. 25, 2024, 13:49 UTC
  • 32
  • 0 comments

FDA approve ACORAMIDIS

Comment Full text

LEGACY PHARMA USA

  • FDA Approval
  • Nov. 25, 2024, 13:49 UTC
  • 28
  • 0 comments

FDA approve TIZANIDINE HYDROCHLORIDE

Comment Full text

LEGACY PHARMA USA

  • FDA Approval
  • Nov. 25, 2024, 13:49 UTC
  • 24
  • 0 comments

FDA approve TIZANIDINE HYDROCHLORIDE

Comment Full text

AOP ORPHAN PHARMACEUTICALS GMBH

  • FDA Approval
  • Nov. 25, 2024, 12:21 UTC
  • 34
  • 0 comments

FDA approve LANDIOLOL

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30
  • 0 comments

FDA approve OMEPRAZOLE; SODIUM BICARBONATE

Comment Full text

UMEDICA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 27
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text
  • Previous
  • 190
  • 191
  • 192
  • 193
  • 194
  • Next

Search

News categories

  • Technical Exchange News(9878)
  • Event(407)
  • SEC News(167316)
  • FDA Approval(9344)
  • Company Report(721)
  • Business News(111212)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin